Idhifa and Sumatriptan and naproxen

• Generic Name: enasidenib
• Dosage Forms: tablet, film coated
• Other Brand Names: Idhifa, Idhifa

IDHIFA (enasidenib) targets a specific gene mutation called IDH2, which can affect your bone marrow. IDH2 mutation prevents young blood cells from developing into healthy adult blood cells, which can result in symptoms of acute myeloid leukemia.

IDHIFA is used to treat acute myeloid leukemia in adults with an IDH2 mutation.

IDHIFA is used when AML has come back or has not improved with prior treatment.

• Generic Name: naproxen / sumatriptan
• Dosage Forms: n.a.
• Other Brand Names: Treximet

Naproxen is a nonsteroidal anti-inflammatory drug (NSAID). Sumatriptan is a migraine headache medicine.

Naproxen and sumatriptan is a combination medicine used to treat migraine headaches. sumatriptan and naproxen will only treat a headache that has already begun. It will not prevent headaches or reduce the number of attacks.

Naproxen and sumatriptan should not be used to treat cluster headaches or any headache that causes loss of movement on one side of your body.

Naproxen and sumatriptan may also be used for purposes not listed in this medication guide.